Magical Trade
Friday, January 27, 2023
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Magical Trade
No Result
View All Result
Home Trade News

Longeveron stock rockets on very heavy volume after upbeat FDA news

by
November 19, 2021
in Trade News
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Intel stock tumbles after brutal results

Do you have a ‘Humpty Dumpty portfolio’? It may be costing you thousands

Shares of Longeveron Inc.
LGVN,
+135.27%

blasted 120.9% higher on very active morning trading Thursday, after the biotechnology company said its Lomecel-B for the treatment of a congenital heart defect in infants (Hypoplastic Left Heart Syndrome) affecting about 1,000 babies a year was granted rare pediatric disease (RPD) designation by the Food and Drug Administration. Trading volume exploded to 112.0 million shares, compared with the full-day average of about 110,000 shares. The stock was both the biggest gainer and most active on major U.S. exchanges. The company said Lomecel-B is currently being evaluated in a Phase 2 trial. Despite the rally, the stock, which went public in February, was still trading well below the initial public offering price of $10 a share. The stock has now climbed 77.7% over the past three months, while the iShares Nasdaq Biotechnology ETF
IBB,
-0.27%

has slipped 8.8% and the S&P 500
SPX,
+0.34%

has gained 6.4%.

ShareTweetPin

Related Posts

Intel stock tumbles after brutal results

by
January 27, 2023
0

In this article INTC Follow your favorite stocksCREATE FREE ACCOUNT Pat Gelsinger, CEO, of Intel Corporation, testifies during the Senate...

Do you have a ‘Humpty Dumpty portfolio’? It may be costing you thousands

by
January 27, 2023
0

When Rick Ferri, a financial advisor and founder of Ferri Investment Solutions, recently saw a new client's portfolio, it conjured...

Three arrested in murder-for-hire plot targeting U.S. journalist who criticized Iran

by
January 27, 2023
0

U.S. Attorney General Merrick Garland announces that the U.S. Justice Department has filed an anti-trust lawsuit against Alphabet's Google over...

White House approves student loan forgiveness for more than 16 million people

by
January 27, 2023
0

Wirestock | Istock | Getty Images The U.S. Department of Education has "fully approved" more than 16 million people for...

What is a ‘rolling recession’ and how does it impact consumers? Economic experts explain

by
January 27, 2023
0

By most measures, the U.S. economy is in solid shape. Although the first half of 2022 started off with negative...

Next Post

The Great Resignation is being driven entirely by this one demographic

FDA clears Moderna and Pfizer's Covid vaccine booster shots for all U.S. adults

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:



By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • Fund manager believes FAANG is dead — says now it’s all about MANTA

    0 shares
    Share 0 Tweet 0
  • Forget Tesla — this auto stock is the one to buy right now, analyst says

    0 shares
    Share 0 Tweet 0
  • Bank of America names its top global tech stocks — including one it says has upside of 100%

    0 shares
    Share 0 Tweet 0
  • Josh Brown says Nvidia’s potential is ‘scary’ ahead of a potential AI boom

    0 shares
    Share 0 Tweet 0
  • Cut Your Retirement Spending Now, Says Creator of the 4% Rule

    0 shares
    Share 0 Tweet 0
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.magicaltrade.net
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

All rights reserved by www.magicaltrade.net